Zhiyuan Tan
Beurs promovendus
- Naam
- Mr. Z. Tan MSc
- Telefoon
- 071 5272727
- z.tan@lacdr.leidenuniv.nl
For more information look at the English website
Beurs promovendus
- Wiskunde en Natuurwetenschappen
- Leiden Academic Centre for Drug Research
- LACDR/Pharmacology
Promovendus
- Wiskunde en Natuurwetenschappen
- Leiden Academic Centre for Drug Research
- LACDR/Pharmacology
Contact
- Tan Z., Völler S., Sancho‐Araiz A., Knibbe C.A.J. & Moes D.J.A.R. (2025), A systematic evaluation of the dosing regimens for approved targeted therapies and immune checkpoint inhibitors in metastatic renal cell carcinoma from a project OPTIMUS perspective, The Journal of Clinical Pharmacology : .
- Tan Z., Völler S., Yin A., Rieborn A., Gelderblom H., Hulle T. van der, Knibbe C.A.J. & Moes D.J.A.R. (2025), Model-informed dose optimization of pazopanib in real-world patients with cancer, Clinical Pharmacokinetics 64(5): 715-728.
- Tan Z., Völler S., Yin A., Rieborn A., Gelderblom A.J., Hulle T. van der, Knibbe C.A.J. & Moes D.J.A.R. (2024), Population pharmacokinetics of cabozantinib in metastatic renal cell carcinoma patients: towards drug expenses saving regimens, Clinical Pharmacokinetics 63(6): 857-869.